MedTrace Logo

Levothyroxine for Children With Euthyroid Sick Syndrome

NCT01631305 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2014-03-05

No results posted yet for this study

Summary

The purpose of this study is to determine whether levothyroxine is effective and safe in the treatment of children with euthyroid sick syndrome, hospitalized in a pediatric intensive care unit.

Conditions

  • Euthyroid Sick Syndrome

Interventions

DRUG

Levothyroxine

3 mcg/kg/day

OTHER

Calcium magnesia

Placebo.

Sponsors & Collaborators

  • Sinaloa Pediatric Hospital

    lead OTHER

Principal Investigators

  • Jesus J Martinez, MD · Sinaloa Pediatric Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01631305 on ClinicalTrials.gov